Fennec Pharmaceuticals, Inc. (FRX.TO)
13.67
-0.04
(-0.29%)
CAD |
TSX |
May 29, 16:00
Fennec Pharmaceuticals Total Liabilities (Quarterly) : 47.65M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bright Minds Biosciences, Inc. | 3.833M |
| Spectral Medical, Inc. | 75.34M |
| Resverlogix Corp. | 137.09M |
| Theratechnologies, Inc. | 108.88M |
| COSCIENS Biopharma, Inc. | 4.915M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 100.23M |
| Shareholders Equity (Quarterly) | 52.58M |
| Current Ratio | 6.977 |
| Net Debt Paydown Yield | 1.81% |